YAP overexpression has been observed in several tumors, and high YAP expression levels have been correlated with poor patient prognosis in ovarian, non-small cell lung cancer and esophageal squamous cell carcinoma [36–38]. This evidence concerns the gene YAP1 and esophageal squamous cell carcinoma.